Abstract
Improvement of quality of life (QoL) is an important goal of COPD management. This single-arm, non-interventional study investigated the effects of add-on roflumilast (Rof) on QoL in routine medical practice by means of the Clinical COPD Questionnaire (CCQ). Also, data on tolerability of treatment with Rof and patients' mental state were collected.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
